Three-dimensional facial volumetric changes in transgender individuals induced by gender-affirming hormone therapy: a stereophotogrammetric assessment.
Mélo A, de Souza C, et al. • Clinical oral investigations • 2025
GAHT produces consistent global differences in facial volumetric patterns between trans men and trans women, with testosterone promoting faster and more uniform masculinization while estrogen associated with an antiandrogen leads to more subtle and regionally distributed feminization over time.
Key Findings
Results
Gender had a significant global multivariate effect on the combined set of facial volumes at all time points in transgender individuals undergoing GAHT.
A multivariate analysis of covariance (MANCOVA) was conducted with facial volumetric regions as dependent variables, followed by post-hoc univariate ANCOVA.
The global multivariate effect of gender on combined facial volumes was significant at all time points (p < 0.001).
The study enrolled 30 participants: 17 transgender men, 1 non-binary transmasculine individual, and 13 transgender women.
Facial scans were obtained at four time points: baseline (T0), 3 months (T1), 6 months (T2), and 12 months (T3) after initiation of GAHT.
Results
Trans men showed a consistent and significant increase in total facial volume and in all five facial regions over the 12-month observation period.
Increases were observed in all five regions analyzed: mandibular, maxillary, frontal, mental (chin), and labial.
The most notable increases were observed between T0 and T1 (baseline to 3 months), and changes were sustained through T3 (12 months).
The pattern of change was described as 'rapid and homogeneous,' particularly pronounced in the lower third of the face.
Trans men (n = 17, plus 1 non-binary transmasculine individual) were receiving testosterone as part of GAHT.
Results
Trans women exhibited more variable and localized facial volumetric changes compared to trans men over the 12-month period.
Trans women (n = 13) showed increases in maxillary, frontal, and labial volumes at T1 and T2.
More widespread volume gains in four of five facial regions were observed at T3 (12 months), suggesting gradual adipose redistribution induced by estradiol.
Trans women's changes were described as 'more subtle and regionally distributed' compared to trans men.
Trans women received estradiol combined with an antiandrogen as part of GAHT.
Results
The mandibular region showed the most pronounced region-specific volumetric changes among all facial regions assessed.
Total facial and mandibular volumes were identified as having the most pronounced region-specific changes between the two groups.
The lower third of the face showed the most notable increases in trans men.
Five facial regions were analyzed: mandibular, maxillary, frontal, mental (chin), and labial.
Stereophotogrammetry using the Vectra H1 device was used for volumetric assessments.
Methods
Spearman's correlation was used to assess associations between weight variation and facial volume changes across participants.
Statistical analysis included the Mann-Whitney U test to compare groups and Spearman's correlation to assess associations between weight variation and facial volume changes.
This was a longitudinal observational study with assessments at four time points over 12 months.
All participants were receiving care at the Gender Diversity Gynecology Clinic (GDIG) of the Hospital das Clínicas, Ribeirão Preto Medical School, University of São Paulo (HCFMRP-USP).
Conclusions
GAHT was found to promote facial characteristics aligned with gender identity in transgender individuals, with distinct patterns of change between transgender men and women.
Testosterone was associated with faster and more uniform masculinization of facial structures.
Estrogen associated with an antiandrogen led to more subtle and regionally distributed feminization over time.
Changes in trans women were attributed to 'gradual adipose redistribution induced by estradiol.'
The study used stereophotogrammetry (Vectra H1) for objective, three-dimensional facial volumetric assessment across 12 months.
Mélo A, de Souza C, de Oliveira Melchior M, de Sousa-Neto M, Lopes-Olhê F, Okano S, et al.. (2025). Three-dimensional facial volumetric changes in transgender individuals induced by gender-affirming hormone therapy: a stereophotogrammetric assessment.. Clinical oral investigations. https://doi.org/10.1007/s00784-025-06577-x